KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma.

MLA

Brown, Brandon M., et al. “KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma.” Current Neuropharmacology, 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1367521780&authtype=sso&custid=ns315887.

APA

Brown, B. M., Brown, B. M., Pressley, B., & Wulff, H. (2018). KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma. Current Neuropharmacology.

Chicago

Brown, Brandon M, Brandon M Brown, Brandon Pressley, and Heike Wulff. 2018. “KCa3.1 Channel Modulators as Potential Therapeutic Compounds for Glioblastoma.” Current Neuropharmacology. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1367521780&authtype=sso&custid=ns315887.